CONSUMER AWARENESS AND ATTITUDE TOWARDS PLANT-BASED ALTERNATIVES FOR PHARMACEUTICALS IN HYDERABAD

Management

Plant-based pharmaceuticals are increasingly being explored as a complementary and alternative approach in diabetes management due to their potential advantages in sustainability, affordability, cultural acceptance, and holistic care. In countries like India, where traditional medicine systems coexist with modern healthcare, plant-based diabetes treatments hold significant promise. However, despite growing market availability and historical use, consumer scepticisms persist regarding their clinical efficacy, safety, standardization, and compatibility with conventional allopathic medicine. Addressing these concerns is essential for their broader acceptance and integration into mainstream diabetes care. This study investigates consumer awareness, perceptions, and attitudes toward plant-based pharmaceutical alternatives for diabetes management among 400 respondents. A quantitative, cross-sectional research design was employed using a structured questionnaire administered through online platforms. The survey captured demographic characteristics, awareness levels, perceived efficacy and safety, prior usage, and willingness to adopt plant-based treatments. Data were analysed using descriptive statistics and chi-square tests in IBM SPSS to examine relationships between awareness, perception, and adoption behaviour. The findings indicate that a majority of respondents possess moderate to high awareness of plant-based diabetes treatments, and a substantial proportion have previously used plant-based ingredients or formulations. While most participants perceive plant-based pharmaceuticals as an effective complementary therapy and acknowledge their affordability, fewer respondents consider them equally effective as conventional anti-diabetic medicines. Importantly, willingness to adopt plant-based treatments increases significantly when recommendations are provided by qualified medical professionals. Chi-square analysis revealed a statistically significant association between consumer awareness and willingness to use plant-based pharmaceuticals (p < 0.05), and an even stronger relationship between perceived efficacy and safety and actual adoption behaviour (p < 0.05). Conversely, no significant relationship was observed between diabetes status and actual usage, indicating a trust gap among diagnosed patients. Overall, the study concludes that although awareness of plant-based pharmaceuticals is rising, consumer acceptance is strongly dependent on scientific validation, physician endorsement, and perceived safety. Strengthening clinical evidence, improving healthcare professional engagement, and implementing targeted educational initiatives are crucial to enhancing trust and expanding the adoption of plant-based pharmaceuticals in diabetes management.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.